(0.08%) 5 473.92 points
(0.10%) 39 152 points
(0.40%) 17 789 points
(-0.24%) $80.64
(-3.66%) $2.66
(-0.76%) $2 313.00
(0.21%) $28.93
(3.54%) $1 021.30
(0.28%) $0.936
(0.70%) $10.68
(0.45%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer\'s and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer\'s disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection...
Stats | |
---|---|
今日成交量 | 272 208 |
平均成交量 | 0 |
市值 | 70.45M |
EPS | $-0.000500 ( Q2 | 2022-08-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.658 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.242 (12.41%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-06-29 | Monohon Ted | Buy | 250 000 | Stock Option (right to buy) |
2022-06-09 | Bray June | Buy | 54 000 | Stock Option (right to buy) |
2022-06-09 | Bray June | Buy | 0 | |
2022-06-08 | Senner Christopher J. | Buy | 27 000 | Stock Option (right to buy) |
2022-06-08 | Ryan Una S | Buy | 27 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 5 069 399 | Sell: 426 503 |
音量 相关性
Cortexyme, Inc. 相关性
10 最正相关 | |
---|---|
DLUSX | 0.863 |
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Cortexyme, Inc. 相关性 - 货币/商品
Cortexyme, Inc. 财务报表
Annual | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-3.02 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-3.02 |
FY | 2020 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-2.63 |
FY | 2019 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-1.940 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cortexyme, Inc.
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer\'s and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer\'s disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。